Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cyclophosphamide therapy in pediatric multiple sclerosis.
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
The refinement of genetic predictors of multiple sclerosis.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells.
Assessment and classification of early stage multiple sclerosis with inertial sensors: comparison against clinical measures of disease state.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.
Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
[Gluten-related disorders and demyelinating diseases.]
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Breastfeeding is associated with lower risk for multiple sclerosis.

Pages